Related Experiment Video
Updated: May 29, 2025
12:44
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
3.7K
Innovations in Glycosaminoglycan Delivery: Transforming Joint Health Therapies
Mahkesha Nisha1, Mohammad Adnan1, Kalyani Sakure1
1Rungta College of Pharmaceutical Science and Research, Bhilai (C.G), India - 490023.
Pharmaceutical Nanotechnology
|February 4, 2025
Summary
Glycosaminoglycan (GAG) therapy shows promise for joint health by reducing arthritis-related deterioration. Further research is needed to optimize GAG delivery systems for improved joint pain treatment and flexibility.
Area of Science:
- Biochemistry
- Orthopedics
- Drug Delivery Systems
Background:
- Joint pain is often linked to the degradation of glycosaminoglycans (GAGs), crucial components of articular cartilage.
- Traditional GAG therapies face limitations in efficacy and delivery.
- There is a growing need for advanced therapeutic strategies to manage joint health and pain.
Purpose of the Study:
- To critically analyze the role of glycosaminoglycans (GAGs) in maintaining joint health.
- To evaluate traditional and novel GAG delivery methods for joint pain management.
- To identify challenges and opportunities in GAG-based therapeutic development.
Main Methods:
- Comprehensive literature review of GAGs in joint health.
- Critical assessment of injectable GAG therapy and oral supplements.
- Exploration of advanced GAG drug delivery technologies (hydrogels, liposomes, nanoparticles).
Main Results:
- Early GAG therapy, especially hyaluronic acid, can mitigate joint deterioration in arthritis by protecting articular cartilage.
- Novel delivery systems show potential for sustained release, enhanced bioavailability, and targeted GAG delivery.
- Current GAG delivery methods face challenges in biocompatibility and safety.
Conclusions:
- GAGs play a vital role in preserving joint structure and function.
- Advanced GAG delivery systems offer promising solutions to overcome limitations of traditional therapies.
- Further investigation is essential to enhance the effectiveness of GAG-based treatments for joint pain, particularly in osteoarthritis.
Related Concept Videos
01:23Glycosaminoglycans
4.7K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
4.7K
01:05Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K